QUICK LINKS
 
bullet Diagnostics
bullet Clinical Diagnostics
bullet Instant Check
bullet Cytoactiv
bullet Bionexia HCG-Combo
bullet Bionexia Strep A Ratio
bullet Bionexia ph-Balance
bullet Bionexia Streptokokken A
bullet Bionexia Streptokokken B
bullet Bionexia Hb/Hp Complex
bullet Bionexia FOBplus
bullet Bionexia Chlamydia Antigen
bullet Real Microbiology *NEW*
bullet Real Plant Diagnostic *NEW*
bullet SASperm *NEW*
bullet

Life Science

bullet

Antibodies

bullet Biological Enzyme Pyrolase
bullet Blot
bullet Cellkines
bullet Clinical Specimens
bullet Custom Panels
bullet Drug Discovery
bullet Elisa
bullet Microbiology & Biochemistry
bullet NATtrol
bullet Oxidative Stress
bullet Real Electrophoresis *NEW*
bullet Real Molecular Biology *NEW*
bullet Seroconversion Panels
bullet Support Reagents
bullet Viral Lysates
bullet Instrumentation
bullet  AUTOBLOT 3000

 
 
 
 

 

 

CYTOACTIV - Scientific references

 

Home Product's description How does it work? Technical Specs Ordering information FAQ

 

16th International Congress of Cytology, May 13-17, 2007, Vancouver Convention & Exhibition Centre, Vancouver, British Columbia, Canada

Cervical and Corpus Uterine Cancer, MECC MonographCharitini Komodiki

Comparative analysis of HPV L1 capsidprotein detection as prognostic marker for mild to moderate dysplastic lesions on conventional smears and ThinPrep monolayers. - Brinkmann-Smetanay F., Jordan B., Weiss A.Center of Pathology and Cytology, Cologne

Immunochemical HPV L1 capsid detection in gynecological smear preparations:Prognostic marker for mild/moderate dysplasiaEXTRACT FROM ISSUE 1/2007,Cyto-Info, MAGAZINE OF THE VDCA · VERBAND DEUTSCHER CYTOLOGISCH TÄTIGER ASSISTENTEN

HPV L1 CAPSID PROTEIN DETECTION BY IMMUNOCHEMISTRY AS PROGNOSTIC MARKER FOR HR HPV ASSOCIATED EARLY SQUAMOUS LESIONS - Griesser, H. ; Sander H.; Hilfrich, R.

HPV L1 CAPSID PROTEIN DETECTION BY IMMUNOCHEMISTRY AS PROGNOSTIC MARKER FOR HR HPV ASSOCIATED EARLY SQUAMOUS LESIONS - Griesser, H. ; Sander H. ; Hilfrich, R. 

HPV viral life cycle - Prof. Dr. H.Griesser, Institute of Pathology and Cytopathology, Würzburg, Germany
Investigation of L1-Protein at HPV inducted deseases of the vulva - Juestel A., Hasche E.G., Bauknecht T., Hagedom M.

Prognostic relevance of HPV L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with a second biomarker p16. - Ralf Hilfrich, PhD ; Jalil Hariri, MD

Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions - D. Rauber, G. Mehlhorn, P.A. Fasching, M.W. Beckmann, S. Ackermann
Update of the prospective study Griesser/Sander/HilfrichECC, Venice 2006

Visualization of HPV L1 Capsid Protein in ASCUS and Mild Dysplasia Cases using a Formaldehyde-free - Fixative and the Cytoblock (Shandon Cytoblock®) Method - P.J.M. Pothuis-Adriolo, E. Ouwerkerk-Noordam, R. Hilfrich, P.A. Holloway, M.E. Boon

 

 

CONTACT US:

 

HHC - Switzerland & Worldwide

sales@helveticahealthcare.com

Tel +41 (0)22 788 8812
Tel +41 (0)22 534 9454
Fax +41 (0) 22 594 8507

HHC - Deutschland

deutschland@helveticahealthcare.com

Tel +49 (0)89 2351 9958


HHC - Italia

italia@helveticahealthcare.com

Tel +39
3284516949

 

HHC - Mexico

mexico@helveticahealthcare.com


We accept credit cards!
 

 

 

NEWS

HHC is sponsoring The European Bio Alpine Convention
(3rd - 4th of December 2008, Geneva)

HHC is honored to be one of the sponsors of the European Bio Alpine Convention which is taking place on 3rd and 4th December 2008. Click here to download the program in pdf or here below to visit their website.
HHC TV is now available!

HHC is pleased to announce that a specific youtube page is now available. This page will be implemented in the next months and furnished with short movies presenting our products and relevant scientific news.
HHC TV link


sitemap - Copyright © 2007 - Helvetica Health Care Sàrl - Last update October 2008